Roundtable Discussion – Challenges & Solutions to Personalized Cancer Immunotherapy From Design to Manufacture

• Overcoming the challenges of small-scale GMP manufacturing capability on CMO/CDMO services for the personalized cancer vaccine, contributing to the increase in cost of manufacturing
• Harmonizing the regulatory guidelines around the personalized cancer vaccine
• Discussing the potential marketability of the personalized cancer vaccines in the future

Speakers:

Seihwan Jeong

Project Leader – Cancer Immunotherapy

LG Chem

Wonil Kim

Chief Scientific Officer

Aston Sci